Novartis $475000 Price Tag Sets the Stage for a Price War With Gilead Sciences – Motley Fool
Market News Call |
Novartis $475000 Price Tag Sets the Stage for a Price War With Gilead Sciences
Motley Fool Novartis' Kymriah and Kite Pharma's (soon to be Gilead Sciences') CAR-Ts work similarly. Each involves removing a patient's T–cells and shipping them to a facility where they're engineered to spot and bind to CD19, a protein commonly expressed by B … Gilead Sciences' Purchase Deal With Kite Pharma: Potential Scenarios And Associated Actions |
